Article History
Received: 8 September 2020
Revised: 2 April 2021
Accepted: 21 April 2021
First Online: 26 May 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Not applicable.
: B.H.P. is a paid consultant for Jackson Labs, Casdin Capital, Pathovax, Sermonix and is a paid scientific advisory board member for Celcuity Inc. Under separate licensing agreements between Horizon Discovery, Ltd and The Johns Hopkins University, S.C. and B.H.P. are entitled to a share of royalties received by the University on sales of products. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. B.A.D. declares no potential conflicts of interest.
: This work was supported by: The Breast Cancer Research Foundation, Komen Foundation, NIH CA214494, CA194024 (B.H.P.). We would also like to thank and acknowledge the support of The Canney Foundation, the Marcie and Ellen Foundation, Amy and Barry Baker, Donna and John Hall and the Vanderbilt-Ingram Cancer Center support grant (NIH CA068485) and Breast Cancer SPORE (NIH CA098131).
Free to read: This content has been made available to all.